{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:00:20Z","timestamp":1791489620667,"version":"4.3.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":221,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101365","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:50:57Z","timestamp":1787032257000},"page":"101365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Validating raloxifene-mediated restoration of DNMT\u2013TET epigenetic balance in breast and lung cancer"],"prefix":"10.1016","volume":"49","author":[{"given":"Chhaya","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolly","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Mohini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaswati","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4551-4182","authenticated-orcid":false,"given":"Amit K.","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101365_bib0001","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1128\/MCB.22.9.2906-2917.2002","article-title":"DNA methyltransferase deficiency modifies cancer susceptibility in mice lacking DNA mismatch repair","volume":"22","author":"Trinh","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ctarc.2026.101365_bib0002","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1042\/EBC20200009","article-title":"Making it or breaking it: DNA methylation and genome integrity","volume":"64","author":"Sriraman","year":"2020","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ctarc.2026.101365_bib0003","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3390\/genes11080922","article-title":"Multifaceted roles of DNA methylation in neoplastic transformation, from tumor suppressors to EMT and metastasis","volume":"11","author":"Casalino","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.ctarc.2026.101365_bib0004","first-page":"1","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ctarc.2026.101365_bib0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13059-015-0699-9","article-title":"An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancer","volume":"16","author":"Yang","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.ctarc.2026.101365_bib0006","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41586-023-06682-5","article-title":"Epigenetic regulation during cancer transitions across 11 tumour types","volume":"623","author":"Terekhanova","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ctarc.2026.101365_bib0007","first-page":"1","article-title":"High expression of DNMT1 in breast invasive carcinoma associated with tumor immune microenvironment and poor prognosis","volume":"1","author":"Chu","year":"2022","journal-title":"Res. Sq."},{"key":"10.1016\/j.ctarc.2026.101365_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-25521-7","article-title":"The concurrence of DNA methylation and demethylation is associated with transcription regulation","volume":"12","author":"Shi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101365_bib0009","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1038\/s41467-021-26093-2","article-title":"TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis","volume":"12","author":"Tulstrup","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101365_bib0010","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3390\/cancers14030830","article-title":"Dissecting TET2 regulatory networks in blood differentiation and cancer","volume":"14","author":"Lazarenkov","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101365_bib0011","first-page":"1","article-title":"The competition between DNA methylation and demethylation is associated with transcription regulation and tumorigenesis","volume":"1","author":"Li","year":"2021","journal-title":"Res. Sq."},{"key":"10.1016\/j.ctarc.2026.101365_bib0012","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3390\/biomedicines11030654","article-title":"Epigenetic regulators of DNA cytosine modification: promising targets for cancer therapy","volume":"11","author":"Jung","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ctarc.2026.101365_bib0013","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41375-020-1003-x","article-title":"Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network","volume":"35","author":"Gu","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.ctarc.2026.101365_bib0014","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ijc.70197","article-title":"DNA methyltransferase inhibitors in hematological malignancies and solid tumors","volume":"158","author":"Wenger","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101365_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-021-01069-7","article-title":"Advances in epigenetic therapeutics with focus on solid tumors","volume":"13","author":"Jin","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.ctarc.2026.101365_bib0016","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/1758834010375759","article-title":"Therapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer","volume":"2","author":"Zeller","year":"2010","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ctarc.2026.101365_bib0017","doi-asserted-by":"crossref","first-page":"75","DOI":"10.31557\/apjcb.2023.8.1.75-89","article-title":"Epigenetics and cancer: a comprehensive review","volume":"8","author":"Pathak","year":"2023","journal-title":"Asian Pac. J. Cancer Biol."},{"key":"10.1016\/j.ctarc.2026.101365_bib0018","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2010.08.001","article-title":"Targeting DNA methylation for epigenetic therapy","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ctarc.2026.101365_bib0019","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3390\/biom15111573","article-title":"Rewriting the fate of cancer: epigenetic and epitranscriptomic regulators in the metastatic cascade","volume":"15","author":"Hara","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.ctarc.2026.101365_bib0020","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3390\/cancers3021691","article-title":"Epigenetics of estrogen receptor signaling: role in hormonal cancer progression and therapy","volume":"3","author":"Mann","year":"2011","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101365_bib0021","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.1038\/ncomms8758","article-title":"DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer","volume":"6","author":"Stone","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101365_bib0022","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41467-019-14098-x","article-title":"Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer","volume":"11","author":"Achinger-Kawecka","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101365_bib0023","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1023\/A:1010019410881","article-title":"Mechanism of action and preclinical profile of raloxifene, a selective estrogen receptor modulator","volume":"2","author":"Bryant","year":"2001","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ctarc.2026.101365_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr742","article-title":"Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy","volume":"6","author":"Shao","year":"2003","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101365_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02383403","article-title":"Raloxifene: a selective estrogen receptor modulator","volume":"12","author":"Sato","year":"1994","journal-title":"J. Bone Miner. Metab."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:36:50Z","timestamp":1791488210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226002765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"alternative-id":["S2468294226002765"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101365","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validating raloxifene-mediated restoration of DNMT\u2013TET epigenetic balance in breast and lung cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101365"}}